Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness.

Silapunt S, Chen L, Migden MR.

Ther Adv Med Oncol. 2016 Sep;8(5):375-82. doi: 10.1177/1758834016653605. Epub 2016 Jun 29. Review.

2.

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.

Chang AL, Arron ST, Migden MR, Solomon JA, Yoo S, Day BM, McKenna EF, Sekulic A.

Orphanet J Rare Dis. 2016 Sep 1;11(1):120. doi: 10.1186/s13023-016-0506-z.

3.

Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies.

Lanoue J, Goldenberg G.

J Clin Aesthet Dermatol. 2016 May;9(5):26-36. Epub 2016 May 1. Review.

4.

An ancient yet flexible cis-regulatory architecture allows localized Hedgehog tuning by patched/Ptch1.

Lorberbaum DS, Ramos AI, Peterson KA, Carpenter BS, Parker DS, De S, Hillers LE, Blake VM, Nishi Y, McFarlane MR, Chiang AC, Kassis JA, Allen BL, McMahon AP, Barolo S.

Elife. 2016 May 5;5. pii: e13550. doi: 10.7554/eLife.13550.

5.

Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment.

Hanna A, Shevde LA.

Mol Cancer. 2016 Mar 18;15:24. doi: 10.1186/s12943-016-0509-3. Review. Erratum in: Mol Cancer. 2016;15(1):35.

6.

Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome).

Bresler SC, Padwa BL, Granter SR.

Head Neck Pathol. 2016 Jun;10(2):119-24. doi: 10.1007/s12105-016-0706-9. Epub 2016 Mar 14.

PMID:
26971503
7.

Ionizing Radiation Exposure and Basal Cell Carcinoma Pathogenesis.

Li C, Athar M.

Radiat Res. 2016 Mar;185(3):217-28. doi: 10.1667/RR4284.S1. Epub 2016 Mar 1. Review.

PMID:
26930381
8.

Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors.

Rimkus TK, Carpenter RL, Qasem S, Chan M, Lo HW.

Cancers (Basel). 2016 Feb 15;8(2). pii: E22. doi: 10.3390/cancers8020022. Review.

9.

Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face.

Feller L, Khammissa RA, Kramer B, Altini M, Lemmer J.

Head Face Med. 2016 Feb 5;12:11. doi: 10.1186/s13005-016-0106-0.

10.

Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.

Chen B, Trang V, Lee A, Williams NS, Wilson AN, Epstein EH Jr, Tang JY, Kim J.

Mol Cancer Ther. 2016 May;15(5):866-76. doi: 10.1158/1535-7163.MCT-15-0729-T. Epub 2016 Jan 28.

PMID:
26823493
11.

DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.

Gruber W, Hutzinger M, Elmer DP, Parigger T, Sternberg C, Cegielkowski L, Zaja M, Leban J, Michel S, Hamm S, Vitt D, Aberger F.

Oncotarget. 2016 Feb 9;7(6):7134-48. doi: 10.18632/oncotarget.6910.

12.

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.

Desai SR, Frieden IJ, Gelfand JM, High W, Kavanaugh A, Marghoob AA, Ozog DM, Rosen T, Stein Gold L, Strober B, Swanson N, Martin G.

J Clin Aesthet Dermatol. 2015 Sep;8(9 Suppl):S4-S26. No abstract available.

13.

AACR Cancer Progress Report 2015.

Baselga J, Bhardwaj N, Cantley LC, DeMatteo R, DuBois RN, Foti M, Gapstur SM, Hahn WC, Helman LJ, Jensen RA, Paskett ED, Lawrence TS, Lutzker SG, Szabo E.

Clin Cancer Res. 2015 Oct 1;21(19 Suppl):S1-128. doi: 10.1158/1078-0432.CCR-15-1846. No abstract available.

PMID:
26429991
14.

Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.

Chaudhary SC, Tang X, Arumugam A, Li C, Srivastava RK, Weng Z, Xu J, Zhang X, Kim AL, McKay K, Elmets CA, Kopelovich L, Bickers DR, Athar M.

Oncotarget. 2015 Nov 3;6(34):36789-814. doi: 10.18632/oncotarget.5103.

15.

Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma.

Jaju PD, Nguyen CB, Mah AM, Atwood SX, Li J, Zia A, Chang AL, Oro AE, Tang JY, Lee CS, Sarin KY.

J Invest Dermatol. 2015 Dec;135(12):3197-200. doi: 10.1038/jid.2015.339. Epub 2015 Sep 8. No abstract available. Erratum in: J Invest Dermatol. 2016 Apr;136(4):882. Nguyen, Christine B [corrected to Nguyen, Christie B].

16.

GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers.

Lee J, Jeong S, Lee CR, Ku CR, Kang SW, Jeong JJ, Nam KH, Shin DY, Chung WY, Lee EJ, Jo YS.

Medicine (Baltimore). 2015 Jun;94(25):e998. doi: 10.1097/MD.0000000000000998.

17.

Advances in the management of basal cell carcinoma.

Lewin JM, Carucci JA.

F1000Prime Rep. 2015 May 12;7:53. doi: 10.12703/P7-53. eCollection 2015. Review.

18.

Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma.

Saito T, Mitomi H, Yao T.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2267-73. eCollection 2015. Review.

19.

Intraflagellar transport 27 is essential for hedgehog signaling but dispensable for ciliogenesis during hair follicle morphogenesis.

Yang N, Li L, Eguether T, Sundberg JP, Pazour GJ, Chen J.

Development. 2015 Jun 15;142(12):2194-202. doi: 10.1242/dev.115261. Epub 2015 May 28. Erratum in: Development. 2015 Aug 15;142(16):2860.

20.

LncRNA BCAR4 wires up signaling transduction in breast cancer.

Xing Z, Park PK, Lin C, Yang L.

RNA Biol. 2015;12(7):681-9. doi: 10.1080/15476286.2015.1053687.

Items per page

Supplemental Content

Write to the Help Desk